No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
PYC Therapeutics Posts Wider Fiscal H1 Loss, Higher Revenue
PYC Therapeutics Ltd: Half Yearly Report and Accounts
PYC Therapeutics to Raise Nearly AU$146 Million via Entitlement Offer
PYC Therapeutics Initiated at Overweight by Barrenjoey
Experts Reveal 4 ASX Small-cap Shares to Buy Now
PYC Therapeutics' (ASX:PYC) Investors Will Be Pleased With Their Splendid 107% Return Over the Last Five Years
